(Reuters) – German biopharmaceutical firm Immatics said on Thursday it plans to collaborate with British drugmaker GlaxoSmithKline (GSK) to develop immunotherapies targeting multiple cancer
Germany’s Immatics ties up with GSK to develop immunotherapies

Air search planned for missing Wahpeton man
52m ago
St. Paul man arrested after Grand Forks pursuit
24m ago
Trump says Tuesday deadline to make a deal with Iran is final
3h ago
FAA proposes to hire 2,300 air traffic controllers in budget request
2h ago
Variety meat exports remain a bright spot for U.S. beef
3h ago
AntonMatyukha / Depositphotos.com
Trump says Iran could be 'taken out' on Tuesday, Hegseth says major strikes to come
58m ago
